Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Terns Pharmaceuticals, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
TERN is no longer listed, so this page shows Q1 2026. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 317
- +76 vs. Q4 2025
- Shares held
- 124.8M
- +11.2M (+9.8%) vs. Q4 2025
- Total value
- $6.56B
- +$1.97B (+43.0%) vs. Q4 2025
- New holders
- 131
- 115 more added
- Sold out
- 55
- 55 more reduced
7 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75.4K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $665.7M |
| Q2 2025 | 130 | $310.0M |
| Q1 2025 | 138 | $229.4M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.1M |
| Q2 2024 | 126 | $446.7M |
| Q1 2024 | 112 | $414.8M |
| Q4 2023 | 103 | $412.7M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.0M |
| Q1 2023 | 79 | $630.2M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.5M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Capula Management Ltd | 120,976 | $6.38M | 0.06% | +120,976 | New |
| Rhumbline Advisers | 123,334 | $6.50M | 0.01% | +17,093+16.1% | Added |
| Alpine Associates Management Inc. | 142,250 | $7.50M | 0.44% | +142,250 | New |
| Deutsche Bank AG | 149,327 | $7.87M | 0.00% | −252,119−62.8% | Reduced |
| Meteora Capital, LLC | 150,000 | $7.91M | 0.58% | +150,000 | New |
| CIBRA Capital Ltd | 151,440 | $7.98M | 3.85% | +151,440 | New |
| New York State Common Retirement Fund | 160,597 | $8.47M | 0.01% | +95,294+145.9% | Added |
| Arnhold LLC | 162,444 | $8.56M | 0.63% | +162,444 | New |
| Voya Investment Management LLC | 165,562 | $8.73M | 0.01% | +43,167+35.3% | Added |
| Schonfeld Strategic Advisors LLC | 165,725 | $8.74M | 0.07% | −588,512−78.0% | Reduced |
| Renaissance Technologies LLC | 169,034 | $8.91M | 0.01% | −297,813−63.8% | Reduced |
| CNH Partners LLC | 171,555 | $9.04M | 0.15% | +171,555 | New |
| PFM Health Sciences, LP | 172,962 | $9.12M | 0.96% | +172,962 | New |
| AQR Capital Management LLC | 176,773 | $9.32M | 0.00% | +130,449+281.6% | Added |
| Diadema Partners LP | 181,752 | $9.58M | 3.96% | −164,128−47.5% | Reduced |
| Water Island Capital LLC | 188,500 | $9.94M | 1.32% | +188,500 | New |
| D. E. Shaw & Co., Inc. | 201,191 | $10.6M | 0.01% | −952,838−82.6% | Reduced |
| Prosight Management, LP | 202,300 | $10.7M | 1.75% | +107,300+112.9% | Added |
| Gabelli & Co Investment Advisers, Inc. | 205,700 | $10.8M | 1.61% | +205,700 | New |
| Absolute Gestao de Investimentos Ltda. | 230,000 | $12.1M | 1.39% | +230,000 | New |
| Blackstone Group Inc. | 231,282 | $12.2M | 0.05% | −245,472−51.5% | Reduced |
| Russell Investments Group, Ltd. | 244,898 | $12.9M | 0.01% | −2,129−0.9% | Reduced |
| Harvest Management LLC | 257,500 | $13.6M | 7.22% | +257,500 | New |
| Tudor Investment Corp Et Al | 267,520 | $14.1M | 0.08% | +194,274+265.2% | Added |
| Gabelli Funds LLC | 271,857 | $14.3M | 0.10% | +271,857 | New |
| Squarepoint Ops LLC | 275,350 | $14.5M | 0.03% | +250,183+994.1% | Added |
| Magnetar Financial LLC | 281,614 | $14.8M | 0.15% | +281,614 | New |
| Bank of New York Mellon Corp | 281,667 | $14.8M | 0.00% | +23,105+8.9% | Added |
| Man Group plc | 284,931 | $15.0M | 0.03% | +284,931 | New |
| FMR LLC | 295,622 | $15.6M | 0.00% | −731,241−71.2% | Reduced |
| Ensign Peak Advisors, Inc | 299,199 | $15.8M | 0.03% | +299,199 | New |
| Atika Capital Management LLC | 300,000 | $15.8M | 2.50% | −21,165−6.6% | Reduced |
| Monashee Investment Management LLC | 300,000 | $15.8M | 8.60% | +102,687+52.0% | Added |
| Cormorant Asset Management, LP | 300,000 | $15.8M | 0.80% | +300,000 | New |
| Invesco Ltd. | 304,487 | $16.1M | 0.00% | −301,760−49.8% | Reduced |
| Davidson Kempner Capital Management LP | 311,623 | $16.4M | 0.29% | +311,623 | New |
| SummitTX Capital, L.P. | 312,181 | $16.5M | 0.53% | +96,327+44.6% | Added |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 321,905 | $17.0M | 0.23% | +321,905 | New |
| First Turn Management, LLC | 326,694 | $17.2M | 1.92% | −545,355−62.5% | Reduced |
| Hudson Bay Capital Management LP | 360,878 | $19.0M | 0.11% | +279,844+345.3% | Added |
| Boxer Capital Management, LLC | 375,000 | $19.8M | 2.60% | 00.0% | Unchanged |
| Maven Securities LTD | 375,000 | $19.8M | 1.15% | +345,000+1,150.0% | Added |
| Wellington Management Group LLP | 375,505 | $19.8M | 0.00% | −413,154−52.4% | Reduced |
| Sculptor Capital LP | 380,000 | $20.0M | 0.23% | +380,000 | New |
| Connor, Clark & Lunn Investment Management Ltd. | 384,681 | $20.3M | 0.05% | +247,203+179.8% | Added |
| LMR Partners LLP | 400,000 | $21.1M | 0.19% | +400,000 | New |
| Catalio Capital Management, LP | 409,031 | $21.6M | 4.50% | +272,073+198.7% | Added |
| Eagle Health Investments LP | 412,497 | $21.7M | 4.57% | +137,407+49.9% | Added |
| Slotnik Capital, LLC | 420,700 | $22.2M | 6.59% | +420,700 | New |
| KVP Capital Advisors, LP | 440,000 | $23.2M | 17.32% | 00.0% | Unchanged |
| Samlyn Capital, LLC | 472,472 | $24.9M | 0.43% | −342,403−42.0% | Reduced |
| Beryl Capital Management LLC | 478,755 | $25.2M | 23.23% | +478,755 | New |
| Neuberger Berman Group LLC | 480,740 | $25.3M | 0.02% | +480,740 | New |
| Boothbay Fund Management, LLC | 486,170 | $25.6M | 0.60% | +39,162+8.8% | Added |
| Acuta Capital Partners, LLC | 495,772 | $26.1M | 18.59% | −141,323−22.2% | Reduced |
| Jennison Associates LLC | 501,419 | $26.4M | 0.02% | +501,419 | New |
| Melqart Asset Management (UK) Ltd | 507,187 | $26.7M | 2.64% | +507,187 | New |
| TIG Advisors, LLC | 511,191 | $26.9M | 1.29% | +511,191 | New |
| Jones Hill Capital LP | 521,237 | $27.5M | 5.89% | +521,237 | New |
| Susquehanna International Group, LLP | 521,571 | $27.5M | 0.04% | +513,974+6,765.5% | Added |
| Octagon Capital Advisors LP | 530,000 | $27.9M | 3.09% | +530,000 | New |
| Qube Research & Technologies Ltd | 537,884 | $28.4M | 0.04% | +530,220+6,918.3% | Added |
| Mariner, LLC | 557,361 | $29.4M | 0.03% | +15,309+2.8% | Added |
| Affinity Asset Advisors, LLC | 562,631 | $29.7M | 1.74% | +12,631+2.3% | Added |
| Vanguard Fiduciary Trust Co | 573,997 | $30.3M | 0.01% | +573,997 | New |
| NEXTBio Capital Management LP | 604,534 | $31.9M | 14.80% | +53,344+9.7% | Added |
| Candriam Luxembourg S.C.A. | 631,636 | $33.3M | 0.17% | −630,667−50.0% | Reduced |
| Price T Rowe Associates Inc | 634,496 | $33.5M | 0.00% | −339,816−34.9% | Reduced |
| Barclays PLC | 669,601 | $35.3M | 0.01% | +498,415+291.2% | Added |
| Fiera Capital Corp | 711,326 | $37.5M | 0.13% | +711,326 | New |
| Vanguard Portfolio Management LLC | 722,389 | $38.1M | 0.00% | +722,389 | New |
| Polar Asset Management Partners Inc. | 725,000 | $38.2M | 0.91% | +725,000 | New |
| Charles Schwab Investment Management Inc | 747,377 | $39.4M | 0.01% | +10,217+1.4% | Added |
| Nuveen, LLC | 772,592 | $40.7M | 0.01% | −305,565−28.3% | Reduced |
| Toronto Dominion Bank | 781,800 | $41.2M | 0.08% | −619,002−44.2% | Reduced |
| Alliancebernstein L.P. | 1,032,679 | $41.7M | 0.01% | −255,400−19.8% | Reduced |
| Verition Fund Management LLC | 802,293 | $42.3M | 0.41% | +789,528+6,185.1% | Added |
| Northern Trust Corp | 805,236 | $42.5M | 0.01% | +140,792+21.2% | Added |
| Bank of America Corp | 811,636 | $42.8M | 0.00% | +258,027+46.6% | Added |
| Fort Baker Capital Management LP | 822,000 | $43.3M | 3.84% | +822,000 | New |
| Vivaldi Asset Management, LLC | 904,161 | $47.7M | 2.50% | +904,161 | New |
| Highland Capital Management Fund Advisors, L.P. | 904,200 | $47.7M | 3.33% | +904,200 | New |
| ADAR1 Capital Management, LLC | 914,699 | $48.2M | 2.90% | +373,084+68.9% | Added |
| Healthcare of Ontario Pension Plan Trust Fund | 924,562 | $48.7M | 0.08% | −590,838−39.0% | Reduced |
| Marshall Wace, LLP | 927,600 | $48.9M | 0.05% | +49,017+5.6% | Added |
| Vestal Point Capital, LP | 1,000,000 | $52.7M | 1.47% | −3,500,000−77.8% | Reduced |
| Whitebox Advisors LLC | 1,000,001 | $52.7M | 0.75% | +1,000,001 | New |
| Deep Track Capital, LP | 1,073,877 | $56.6M | 1.17% | +304,829+39.6% | Added |
| Goldman Sachs Group Inc | 1,106,961 | $58.4M | 0.01% | +43,977+4.1% | Added |
| UBS Group AG | 1,228,726 | $64.8M | 0.01% | +902,758+276.9% | Added |
| Dimensional Fund Advisors LP | 1,247,845 | $65.8M | 0.01% | +820.0% | Added |
| Vivo Capital, LLC | 1,334,418 | $70.4M | 5.85% | −4,012,510−75.0% | Reduced |
| Capital International Investors | 1,424,504 | $75.1M | 0.02% | +364,504+34.4% | Added |
| Ikarian Capital, LLC | 1,456,378 | $76.8M | 10.98% | −140,000−8.8% | Reduced |
| Janus Henderson Group PLC | 1,470,057 | $77.5M | 0.04% | −1,909,512−56.5% | Reduced |
| Logos Global Management LP | 1,500,000 | $79.1M | 4.07% | +750,000+100.0% | Added |
| Pictet Asset Management Holding SA | 1,655,575 | $87.3M | 0.09% | +78,459+5.0% | Added |
| Acorn Capital Advisors, LLC | 1,746,264 | $92.1M | 26.17% | 00.0% | Unchanged |
| Capitolis Liquid Global Markets LLC | 1,975,800 | $104.2M | 0.66% | +1,975,800 | New |
| Adage Capital Partners GP, L.L.C. | 2,124,817 | $112.0M | 0.17% | −3,425,183−61.7% | Reduced |